These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The efficacy and tolerance of cefoxitin in the treatment of paediatric infections. Gnehm HE; Seger RA; Boyle CM Curr Med Res Opin; 1982; 8(1):44-50. PubMed ID: 7105821 [TBL] [Abstract][Full Text] [Related]
44. Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections. Weinstein MP; Eickhoff TC Rev Infect Dis; 1979; 1(1):158-64. PubMed ID: 318217 [TBL] [Abstract][Full Text] [Related]
45. Intravenous cefoxitin sodium for the treatment of infections in obstetric and gynaecological patients. Galask RP; Ohm M J Antimicrob Chemother; 1978 Jul; 4(B):241-3. PubMed ID: 690024 [No Abstract] [Full Text] [Related]
46. [Clinical experience with cefoxitin in bacterial infections of children (author's transl)]. Yuasa Y; Ichioka T; Sekiguchi T; Miyao M; Toi C; Hayashi K; Yamashita K; Tanaka H Jpn J Antibiot; 1981 Mar; 34(3):359-66. PubMed ID: 7289028 [TBL] [Abstract][Full Text] [Related]
48. Clinical safety and tolerance of cefoxitin sodium: an overview. van Winzum C J Antimicrob Chemother; 1978 Jul; 4(B):91-104. PubMed ID: 357400 [No Abstract] [Full Text] [Related]
49. Clinical efficacy of cefoxitin in the treatment of head and neck infections. Shamsuddin D; Tuazon CU Arch Otolaryngol; 1981 Apr; 107(4):242-4. PubMed ID: 7213184 [TBL] [Abstract][Full Text] [Related]
51. Clinical and bacteriological evaluation of cefoxitin therapy in children. Jacobson JA; Santos JI; Palmer WM Antimicrob Agents Chemother; 1979 Aug; 16(2):183-5. PubMed ID: 485129 [TBL] [Abstract][Full Text] [Related]
52. Treatment of skin and soft tissue infections with imipenem/cilastatin. Fass RJ; Freimer EH; McCloskey RV Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532 [TBL] [Abstract][Full Text] [Related]
53. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections. Larsen JW; Voise CT; Grossman JH Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461 [TBL] [Abstract][Full Text] [Related]
54. [Clinical trial of cefoxitin used in the treatment of patients with cholesteatoma undergoing surgical procedures]. Morikawa K Jpn J Antibiot; 1982 Dec; 35(12):2761-7. PubMed ID: 7182531 [TBL] [Abstract][Full Text] [Related]
55. Intravenous cefoxitin sodium in the treatment of urinary tract infections. Cox CE J Antimicrob Chemother; 1978 Jul; 4(B):193-5. PubMed ID: 357385 [No Abstract] [Full Text] [Related]
56. [Treatment and prevention of infections with cefoxitin sodium in patients with biliary tract infections and obstructive jaundice]. Fuji T; Harima K; Ariyama S; Maetani N; Nagatomi Y; Kawashima M; Aibe T; Amano H; Asagami F; Goto T; Kawamura S; Takemoto T Jpn J Antibiot; 1982 Aug; 35(8):1987-92. PubMed ID: 7154246 [TBL] [Abstract][Full Text] [Related]
57. [Some experiences in the field of pediatrics with cefoxitin treatment by intravenous injections (author's transl)]. Hirama Y; Iwasaki A; Suzuki H; Nakazawa S; Narita A; Niino K; Sato H; Nakazawa S; Chikaoka H; Oka S Jpn J Antibiot; 1981 Mar; 34(3):244-56. PubMed ID: 7289019 [TBL] [Abstract][Full Text] [Related]
58. In vitro and clinical evaluation of ceforanide. Lefrock JL; Holloway W; Carr BB; Schell RF Am J Med Sci; 1984; 287(2):21-5. PubMed ID: 6711584 [TBL] [Abstract][Full Text] [Related]
59. Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections). File TM; Tan JS Am J Med; 1983 Aug; 75(2A):100-5. PubMed ID: 6310996 [TBL] [Abstract][Full Text] [Related]
60. Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections. Conway EL; Sellick JA; Kurtzhalts K; Mergenhagen KA Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]